These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 9972970)
1. Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Duhaut P; Bosshard S; Calvet A; Pinede L; Demolombe-Rague S; Dumontet C; Loire R; Seydoux D; Ninet J; Pasquier J; Aymard M J Rheumatol; 1999 Feb; 26(2):361-9. PubMed ID: 9972970 [TBL] [Abstract][Full Text] [Related]
2. Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Duhaut P; Berruyer M; Pinede L; Demolombe-Rague S; Loire R; Seydoux D; Dechavanne M; Ninet J; Pasquier J Arthritis Rheum; 1998 Apr; 41(4):701-9. PubMed ID: 9550480 [TBL] [Abstract][Full Text] [Related]
3. Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Duhaut P; Pinede L; Demolombe-Rague S; Loire R; Seydoux D; Ninet J; Pasquier J Arthritis Rheum; 1998 Nov; 41(11):1960-5. PubMed ID: 9811050 [TBL] [Abstract][Full Text] [Related]
4. Giant cell arteritis and polymyalgia rheumatica: role of viral infections. Duhaut P; Bosshard S; Dumontet C Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S22-3. PubMed ID: 10948753 [TBL] [Abstract][Full Text] [Related]
5. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis. Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347 [TBL] [Abstract][Full Text] [Related]
6. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. Elling P; Olsson AT; Elling H J Rheumatol; 1996 Jan; 23(1):112-9. PubMed ID: 8838518 [TBL] [Abstract][Full Text] [Related]
8. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94. Gran JT; Myklebust G J Rheumatol; 1997 Sep; 24(9):1739-43. PubMed ID: 9292797 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis. Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442 [TBL] [Abstract][Full Text] [Related]
10. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications. Espinoza LR; Jara LJ; Silveira LH; Martínez-Osuna P; Zwolinska JB; Kneer C; Aguilar JL Am J Med; 1991 Apr; 90(4):474-8. PubMed ID: 2012088 [TBL] [Abstract][Full Text] [Related]
11. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. González-Gay MA; García-Porrúa C; Vázquez-Caruncho M J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456 [TBL] [Abstract][Full Text] [Related]
12. No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. Myklebust G; Wilsgaard T; Jacobsen BK; Gran JT J Rheumatol; 2002 Oct; 29(10):2143-7. PubMed ID: 12375324 [TBL] [Abstract][Full Text] [Related]
13. Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica. Baerlecken NT; Linnemann A; Gross WL; Moosig F; Vazquez-Rodriguez TR; Gonzalez-Gay MA; Martin J; Kötter I; Henes JC; Melchers I; Vaith P; Schmidt RE; Witte T Ann Rheum Dis; 2012 Jun; 71(6):943-7. PubMed ID: 22228484 [TBL] [Abstract][Full Text] [Related]
14. Lack of association between infection and onset of polymyalgia rheumatica. Narváez J; Clavaguera MT; Nolla-Solé JM; Valverde-Garcia J; Roig-Escofet D J Rheumatol; 2000 Apr; 27(4):953-7. PubMed ID: 10782822 [TBL] [Abstract][Full Text] [Related]
15. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988. Franzén P; Sutinen S; von Knorring J J Rheumatol; 1992 Feb; 19(2):273-6. PubMed ID: 1629827 [TBL] [Abstract][Full Text] [Related]
16. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity. Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290 [TBL] [Abstract][Full Text] [Related]
17. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review. Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026 [TBL] [Abstract][Full Text] [Related]
18. [Synchronous variations in the incidence of temporal arteritis and polymyalgia rheumatica in Danish counties. Association with epidemics of Mycoplasma pneumonia infection]. Elling P; Olsson AT; Elling H Ugeskr Laeger; 1997 Jun; 159(26):4123-8. PubMed ID: 9229871 [TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica. Berthelot JM; Lamour A; Mottier D; Pennec YL; Dueymes M; Jouquan J; Le Goff P; Youinou P Ann Med Interne (Paris); 1992; 143(7):429-32. PubMed ID: 1300861 [TBL] [Abstract][Full Text] [Related]
20. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis. Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]